• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四味中药 PHY906 可降低化疗引起的胃肠道毒性。

The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.

机构信息

Yale University School of Medicine, New Haven, CT 06520, USA.

出版信息

Sci Transl Med. 2010 Aug 18;2(45):45ra59. doi: 10.1126/scitranslmed.3001270.

DOI:10.1126/scitranslmed.3001270
PMID:20720216
Abstract

PHY906, a four-herb Chinese medicine formula first described 1800 years ago, decreases gastrointestinal toxicity induced by the chemotherapeutic drug CPT-11 (irinotecan), as shown in a phase I/II clinical study. Similarly, in a murine colon 38 allograft model, PHY906 increased the antitumor activity of CPT-11 while decreasing animal weight loss caused by CPT-11. Here, we have further examined the effect of PHY906 on the intestinal toxicity caused by CPT-11 in mice. PHY906 did not protect against the initial DNA damage and apoptosis triggered by CPT-11 in the intestine, but by 4 days after CPT-11 treatment, PHY906 had restored the intestinal epithelium by promoting the regeneration of intestinal progenitor or stem cells and several Wnt signaling components. PHY906 also potentiated Wnt3a activity in human embryonic kidney-293 cells. Furthermore, PHY906 exhibited anti-inflammatory effects in mice by decreasing the infiltration of neutrophils or macrophages, tumor necrosis factor-alpha expression in the intestine, and proinflammatory cytokine concentrations in plasma. Chemical constituents of PHY906 potently inhibited nuclear factor kappaB, cyclooxygenase-2, and inducible nitric oxide synthase. Our results show that the herbal medicine PHY906 can counteract the toxicity of CPT-11 via several mechanisms that act simultaneously.

摘要

PHY906 是一种四味中药配方,最早在 1800 年前被描述,可降低化疗药物伊立替康(CPT-11)引起的胃肠道毒性,这在一项 I/II 期临床试验中得到了证实。同样,在小鼠结肠 38 同种异体移植模型中,PHY906 增加了 CPT-11 的抗肿瘤活性,同时减少了 CPT-11 引起的动物体重减轻。在这里,我们进一步研究了 PHY906 对 CPT-11 引起的小鼠肠道毒性的影响。PHY906 不能预防 CPT-11 在肠道中引发的初始 DNA 损伤和细胞凋亡,但在 CPT-11 治疗 4 天后,PHY906 通过促进肠前体细胞或干细胞的再生和几种 Wnt 信号成分,恢复了肠道上皮。PHY906 还增强了人胚肾-293 细胞中 Wnt3a 的活性。此外,PHY906 通过减少中性粒细胞或巨噬细胞的浸润、肠道中肿瘤坏死因子-α的表达和血浆中促炎细胞因子的浓度,在小鼠中表现出抗炎作用。PHY906 的化学成分强烈抑制核因子 kappaB、环氧化酶-2 和诱导型一氧化氮合酶。我们的结果表明,草药 PHY906 可以通过几种同时作用的机制来对抗 CPT-11 的毒性。

相似文献

1
The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.四味中药 PHY906 可降低化疗引起的胃肠道毒性。
Sci Transl Med. 2010 Aug 18;2(45):45ra59. doi: 10.1126/scitranslmed.3001270.
2
The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018).肠道细菌的数量对于中药PHY906(KD018)增强伊立替康的抗肿瘤活性及降低其肠道毒性而言并非关键因素。
BMC Complement Altern Med. 2014 Dec 15;14:490. doi: 10.1186/1472-6882-14-490.
3
Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.中药 PHY906 与 CPT-11 对肿瘤微环境中炎症过程的相互作用。
BMC Med Genomics. 2011 May 11;4:38. doi: 10.1186/1755-8794-4-38.
4
A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.一项中药 PHY906 作为晚期结直肠癌伊立替康为基础化疗的调节剂的 I 期研究。
Clin Colorectal Cancer. 2011 Jun;10(2):85-96. doi: 10.1016/j.clcc.2011.03.003. Epub 2011 Apr 22.
5
Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice.中药葛根芩连汤改善小鼠伊立替康化疗引起的肠道毒性。
Biomed Pharmacother. 2019 Jan;109:2252-2261. doi: 10.1016/j.biopha.2018.11.095. Epub 2018 Nov 28.
6
Are herbal medicines ripe for the cancer clinic?草药是否已准备好在癌症临床应用?
Sci Transl Med. 2010 Aug 18;2(45):45ps41. doi: 10.1126/scitranslmed.3001517.
7
Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.伊立替康(CPT-11)与小鼠回肠和盲肠的特征性黏膜变化
J Natl Cancer Inst. 1995 Dec 20;87(24):1876-83. doi: 10.1093/jnci/87.24.1876.
8
Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats.汉方药和黄芩苷对新型抗癌喜树碱衍生物盐酸伊立替康(CPT-11)所致大鼠肠道毒性的保护作用。
Jpn J Cancer Res. 1995 Oct;86(10):978-84. doi: 10.1111/j.1349-7006.1995.tb03010.x.
9
A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor.一项关于联合使用沙利度胺(一种肿瘤坏死因子-α抑制剂)降低伊立替康毒性的机制研究。
J Pharmacol Exp Ther. 2006 Oct;319(1):82-104. doi: 10.1124/jpet.106.103606. Epub 2006 Jun 30.
10
Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model.阿片类药物诱导的微生物失调破坏伊立替康(CPT-11)代谢并增加小鼠模型中的胃肠道毒性。
Br J Pharmacol. 2023 May;180(10):1362-1378. doi: 10.1111/bph.16020. Epub 2023 Jan 9.

引用本文的文献

1
Integration of Untargeted Metabolomics, Network Pharmacology, Single-Cell RNA Sequencing, and Molecular Dynamics Simulation Reveals GOT1, CYP1A2, and CA2 as Potential Targets of Huang Qin Decoction Preventing Colorectal Cancer Liver Metastasis.非靶向代谢组学、网络药理学、单细胞RNA测序和分子动力学模拟相结合揭示谷草转氨酶1、细胞色素P450 1A2和碳酸酐酶2是黄芩汤预防结直肠癌肝转移的潜在靶点。
Pharmaceuticals (Basel). 2025 Jul 17;18(7):1052. doi: 10.3390/ph18071052.
2
The western transmission of traditional Chinese medicine: an investigation of the cultural elements of traditional Chinese medicine in biomedical systems of cross-Asia countries.中医在西方的传播:对跨亚洲国家生物医学体系中中医文化元素的调查
Front Pharmacol. 2025 Jul 7;16:1589275. doi: 10.3389/fphar.2025.1589275. eCollection 2025.
3
Therapeutic Effect of Oil Emulsion in Mice with Irinotecan-Induced Delayed Diarrhea.油乳剂对伊立替康诱导的小鼠迟发性腹泻的治疗作用
Drug Des Devel Ther. 2025 Jun 24;19:5329-5347. doi: 10.2147/DDDT.S517973. eCollection 2025.
4
Advanced Pharmaceutical Nanotechnologies Applied for Chinese Herbal Medicines.应用于中草药的先进药物纳米技术
Adv Sci (Weinh). 2025 Aug;12(31):e00167. doi: 10.1002/advs.202500167. Epub 2025 Jun 20.
5
Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment.管理伊立替康所致腹泻:癌症治疗中治疗干预措施的全面综述
Pharmaceuticals (Basel). 2025 Mar 2;18(3):359. doi: 10.3390/ph18030359.
6
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).结直肠癌肝转移的发病机制、诊断及临床治疗方法(综述)
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5728. Epub 2025 Feb 14.
7
Unlocking the therapeutic mechanism of : a comprehensive review of its antioxidant and anti-cancer properties, ethnopharmacology, and phytochemistry.揭开[具体名称]的治疗机制:对其抗氧化和抗癌特性、民族药理学及植物化学的全面综述 。 需注意,原文中“Unlocking the therapeutic mechanism of :”这里冒号前不完整,缺少具体所指内容。
Front Pharmacol. 2025 Jan 7;15:1514573. doi: 10.3389/fphar.2024.1514573. eCollection 2024.
8
Targeted inhibition of Gus-expressing to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol.靶向抑制表达Gus的细胞以促进肠道干细胞和上皮更新,有助于减轻脱氢二异丁香酚对伊立替康化学毒性的缓解作用。
Acta Pharm Sin B. 2024 Dec;14(12):5286-5304. doi: 10.1016/j.apsb.2024.09.018. Epub 2024 Oct 18.
9
Antibacterial effects of Kampo products against pneumonia causative bacteria.汉方药产品对肺炎致病菌的抗菌作用。
PLoS One. 2024 Oct 28;19(10):e0312500. doi: 10.1371/journal.pone.0312500. eCollection 2024.
10
Three bioactive compounds from Huangqin decoction ameliorate Irinotecan-induced diarrhea via dual-targeting of Escherichia coli and bacterial β-glucuronidase.黄芩汤中的三种生物活性化合物通过靶向大肠杆菌和细菌β-葡萄糖醛酸酶双重作用改善伊立替康所致腹泻。
Cell Biol Toxicol. 2024 Oct 18;40(1):88. doi: 10.1007/s10565-024-09922-0.